Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease

Journal of Clinical Laboratory Analysis

Volumn 32, Issue 7, 2018, Pages

  Xu, Yahuan ^a   Shao, Bibo ^a  

^a HUBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

coronary artery disease; disease risk; Gensini Score; inflammatory cytokines; lncRNA IFNG AS1

Indexed keywords

C REACTIVE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSECTIN; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA ANRIL; LONG UNTRANSLATED RNA IFNG AS1; LONG UNTRANSLATED RNA ITSN1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE; GAMMA INTERFERON; IFNG PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CARDITIS; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENSINI SCORE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; UPREGULATION; AGED; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; RISK FACTORS; RNA, LONG NONCODING; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 85046641684     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22452     Document Type: Article

References (34)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-171.
2. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545-1602.
3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544.
4. Mehta PK, Wei J, Wenger NK. Ischemic heart disease in women: a focus on risk factors. Trends Cardiovasc Med. 2015;25:140-151.
5. Charlson FJ, Moran AE, Freedman G, et al. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med. 2013;11:250.
6. Dai X, Wiernek S, Evans JP, Runge MS. Genetics of coronary artery disease and myocardial infarction. World J Cardiol. 2016;8:1-23.
7. Chaudhary R, Chauhan A, Singhal M, Bagga S. Risk factor profiling and study of atherosclerotic coronary plaque burden and morphology with coronary computed tomography angiography in coronary artery disease among young Indians. Int J Cardiol. 2017;240:452-457.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
9. Athanasiadis A, Sechtem U, European Society of Cardiology. [Diagnostics and therapy of chronic stable coronary artery disease: new guidelines of the European Society of Cardiology]. Herz. 2014;39:902-912.
10. Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47-62.
11. Gao W, Zhu M, Wang H, et al. Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat Res. 2015;772:15-22.
12. Yang Y, Cai Y, Wu G, et al. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin Sci (Lond). 2015;129:675-685.
13. Shahmoradi N, Nasiri M, Kamfiroozi H, Kheiry MA. Association of the rs555172 polymorphism in SENCR long non-coding RNA and atherosclerotic coronary artery disease. J Cardiovasc Thorac Res. 2017;9:170-174.
14. Li X, Zhao Z, Gao C, et al. Identification of a peripheral blood Long non-coding RNA (Upperhand) as a potential diagnostic marker of coronary artery disease. Cardiol J. 2017. https://doi.org/10.5603/CJ.a2017.0133. [Epub ahead of print].
15. Padua D, Mahurkar-Joshi S, Law IK, et al. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. Am J Physiol Gastrointest Liver Physiol. 2016;311:G446-G457.
16. Song CL, Wang JP, Xue X, et al. Effect of circular ANRIL on the inflammatory response of vascular endothelial cells in a rat model of coronary atherosclerosis. Cell Physiol Biochem. 2017;42:1202-1212.
17. Gong X, Fan X, Zhang Z, et al. Circulating lnc-ITSN1-2 expression presents a high value in diagnosis of rheumatoid arthritis and correlates with disease activity. Int J Clin Exp Pathol. 2017;10:10451-10458.
18. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med. 2005;352:2524-2533.
19. Simoons ML, Windecker S. Controversies in cardiovascular medicine: chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J. 2010;31:530-541.
20. Ott SJ, El Mokhtari NE, Musfeldt M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation. 2006;113:929-937.
21. Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361-403.
22. Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316-320.
23. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145-166.
24. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904-914.
25. Zhang Z, Gao W, Long QQ, et al. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep. 2017;7:7491.
26. Zhang BY, Jin Z, Zhao Z. Long intergenic noncoding RNA 00305 sponges miR-136 to regulate the hypoxia induced apoptosis of vascular endothelial cells. Biomed Pharmacother. 2017;94:238-243.
27. Liu W, Liu X, Luo M, et al. dNK derived IFN-gamma mediates VSMC migration and apoptosis via the induction of LncRNA MEG3: a role in uterovascular transformation. Placenta. 2017;50:32-39.
28. Yu C, Li L, Xie F, et al. LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res. 2017;114:168-179.
29. Peng H, Liu Y, Tian J, et al. The long noncoding RNA IFNG-AS1 promotes T helper type 1 cells response in patients with Hashimoto's thyroiditis. Sci Rep. 2015;5:17702.
30. Luo M, Liu X, Meng H, et al. IFNA-AS1 regulates CD4(+) T cell activation in myasthenia gravis though HLA-DRB1. Clin Immunol. 2017;183:121-131.
31. Nie FQ, Sun M, Yang JS, et al. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015;14:268-277.
32. Zhang D, Sun G, Zhang H, Tian J, Li Y. Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed Pharmacother. 2017;85:511-516.
33. Zacharopoulou E, Gazouli M, Tzouvala M, Vezakis A, Karamanolis G. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases. Dig Liver Dis. 2017;49:1067-1072.
34. Chi JS, Li JZ, Jia JJ, Zhang T, Liu XM, Yi L. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. J Huazhong Univ Sci Technolog Med Sci. 2017;37:816-822.